Cite
APA Citation
Danta, M. (2012). telaprevir triple combination therapy, and dual peginterferon α-2a/ribavirin therapy for 24 weeks for those with rapid-early response is not inferior to 48 weeks of therapy for treatment-naïve patients with genotype 1 hepatitis C virus infection. Evidence-based medicine, 17(5), 143–144. http://access.bl.uk/ark:/81055/vdc_100142950786.0x000004